Cargando…

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside

Immune checkpoint inhibitor (ICI)-related inflammatory diseases, including polymyositis (PM) and dermatomyositis (DM), in patients suffering from neoplastic disorders represent a medical challenge. The treatment of these conditions has taken on new urgency due to the successful and broad development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solimando, Antonio G., Crudele, Lucilla, Leone, Patrizia, Argentiero, Antonella, Guarascio, Matteo, Silvestris, Nicola, Vacca, Angelo, Racanelli, Vito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246673/ https://www.ncbi.nlm.nih.gov/pubmed/32357515 http://dx.doi.org/10.3390/ijms21093054

Ejemplares similares

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
por: Leone, Patrizia, et al.
Publicado: (2021)

Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
por: Argentiero, Antonella, et al.
Publicado: (2020)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Actors on the Scene: Immune Cells in the Myeloma Niche
por: Leone, Patrizia, et al.
Publicado: (2020)

Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
por: Argentiero, Antonella, et al.
Publicado: (2019)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass
por: Cicco, Sebastiano, et al.
Publicado: (2018)

Common Variable Immunodeficiency and Gastric Malignancies
por: Leone, Patrizia, et al.
Publicado: (2018)

Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
por: Leone, Patrizia, et al.
Publicado: (2019)

Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment
por: Javadrashid, Darya, et al.
Publicado: (2021)

Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis
por: Fasano, Rossella, et al.
Publicado: (2022)

Integrated lung ultrasound score for early clinical decision-making in patients with COVID-19: results and implications
por: Dell’Aquila, Paola, et al.
Publicado: (2022)

Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice
por: Buonavoglia, Alessio, et al.
Publicado: (2021)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
por: Burgaletto, Chiara, et al.
Publicado: (2021)

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma
por: Leone, Patrizia, et al.
Publicado: (2023)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Bench to bedside review of myositis autoantibodies
por: Palterer, Boaz, et al.
Publicado: (2018)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
por: Zito, Concetta, et al.
Publicado: (2022)

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Checkpoint inhibitor induced myositis – The value of MRI STIR
por: Erritzøe-Jervild, Mai, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
por: Makaremi, Shima, et al.
Publicado: (2021)

Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study
por: Cicco, Sebastiano, et al.
Publicado: (2020)

Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
por: Solimando, Antonio Giovanni, et al.
Publicado: (2020)

Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma
por: Rao, Luigia, et al.
Publicado: (2020)

Editorial: Targeting antigen processing and presentation in autoimmune and autoinflammatory disorders
por: Leone, Patrizia, et al.
Publicado: (2022)

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
por: Lamanuzzi, Aurelia, et al.
Publicado: (2018)

Rituximab in Refractory Myositis and Acute Neuropathy Secondary to Checkpoint Inhibitor Therapy
por: Jain, Varun, et al.
Publicado: (2022)

Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy
por: Katyal, Nakul, et al.
Publicado: (2023)

Lupus Vasculitis: An Overview
por: Leone, Patrizia, et al.
Publicado: (2021)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
por: Desantis, Vanessa, et al.
Publicado: (2020)

Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
por: Cicco, Sebastiano, et al.
Publicado: (2020)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
por: Ria, Roberto, et al.
Publicado: (2020)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Buonavoglia, Alessio, et al.
Publicado: (2021)

Antibody V(h) Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections
por: Racanelli, Vito, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9un9e972s8fu7tffon6ac7lr0p